Ingevity (NGVT) EBIT (2015 - 2026)

Ingevity (NGVT) has 12 years of EBIT data on file, last reported at $68.5 million in Q1 2026.

• On a quarterly basis, EBIT rose 12.11% year-over-year to $68.5 million in Q1 2026; TTM through Mar 2026 was $272.3 million, a 8.06% increase from a year earlier, with the FY2025 full-year figure at $249.1 million, down 5.79% from the prior year.
• EBIT for Q1 2026 stood at $68.5 million, up from $36.1 million in the prior quarter.
• Over the last five years, EBIT for NGVT reached as high as $111.2 million in Q3 2022 and fell as low as $10.5 million in Q4 2023.
• Historically, EBIT has averaged $65.5 million across 5 years, with a median of $67.4 million in 2023.
• Across the five-year window, EBIT sank 73.21% in 2023 and jumped 331.43% in 2024, its largest moves.
• Year by year, EBIT stood at $39.2 million in 2022, then slumped by 73.21% to $10.5 million in 2023, then soared by 331.43% to $45.3 million in 2024, then declined by 20.31% to $36.1 million in 2025, then surged by 89.75% to $68.5 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were $68.5 million in Q1 2026, $36.1 million in Q4 2025, and $81.8 million in Q3 2025.